Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-01

Clinical Trial Update: Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating aspirin withdrawal in non-ischemic cardiomyopathy (heart failure) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: The Alfred | Conditions: Heart Failure | Phase 4 | Status: COMPLETED